Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

14.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Energy to Drive Translocation01:37

Energy to Drive Translocation

2.1K
Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIRA-mediated H3.3 deposition preserves hepatocyte cell identity during liver aging.

Research square·2026
Same author

CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinoma.

bioRxiv : the preprint server for biology·2026
Same author

Estradiol Reprograms Microglia to Create an Immune-Suppressed Niche Permissive to Breast Cancer Brain Metastasis.

bioRxiv : the preprint server for biology·2026
Same author

Modulation of the immunogenic landscape in colorectal cancer by mitochondrial methylation-controlled J protein.

Molecular biomedicine·2026
Same author

Evidence and Tradition in Dialogue: Biological Sex Variability in Phytomedicine Research as a Foundation for Safety, Efficacy, and Robust Evidence Standards.

Medicines (Basel, Switzerland)·2026
Same author

Publisher Correction: Atlas-guided discovery of transcription factors for T cell programming.

Nature·2026

Related Experiment Video

Updated: Jul 16, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.4K

Manipulating mitochondrial electron flow enhances tumor immunogenicity.

Kailash Chandra Mangalhara1, Siva Karthik Varanasi1, Melissa A Johnson1

  • 1Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

Science (New York, N.Y.)
|September 21, 2023
PubMed
Summary
This summary is machine-generated.

Loss of mitochondrial complex II, not complex I, slows melanoma growth by enhancing T cell responses. Rewiring the electron transport chain offers a potential cancer therapy strategy.

More Related Videos

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry
07:57

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Published on: December 26, 2019

12.2K
Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates
11:32

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

2.7K

Related Experiment Videos

Last Updated: Jul 16, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

2.4K
Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry
07:57

Measurement of Mitochondrial Mass and Membrane Potential in Hematopoietic Stem Cells and T-cells by Flow Cytometry

Published on: December 26, 2019

12.2K
Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates
11:32

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

2.7K

Area of Science:

  • Cancer Biology
  • Immunology
  • Mitochondrial Metabolism

Background:

  • Tumor growth depends on the mitochondrial electron transport chain (ETC).
  • The distinct roles of ETC complex I (CI) and complex II (CII) in tumor progression are not fully understood.
  • Understanding these roles is crucial for developing novel cancer therapies.

Purpose of the Study:

  • To investigate the differential roles of CI and CII in melanoma tumor growth.
  • To explore the impact of ETC modulation on immune responses and tumor control.
  • To assess the therapeutic potential of targeting ETC components for cancer treatment.

Main Methods:

  • Utilized melanoma cell models with genetic knockouts of CI and CII.
  • Analyzed tumor growth rates and immune cell infiltration.
  • Investigated gene expression and epigenetic modifications related to antigen presentation.
  • Employed genetic manipulation (MCJ knockout) to rewire ETC electron entry.

Main Results:

  • Loss of CII, but not CI, significantly reduced melanoma tumor growth.
  • CII deficiency enhanced antigen presentation and T cell-mediated tumor killing.
  • Succinate accumulation activated major histocompatibility complex-antigen processing and presentation (MHC-APP) genes.
  • MCJ knockout demonstrated a strategy for ETC rewiring to promote anti-tumor immunity.

Conclusions:

  • CII plays a critical role in supporting melanoma tumor growth.
  • Targeting CII or modulating ETC pathways can enhance anti-tumor immune responses.
  • ETC rewiring represents a promising therapeutic avenue for cancers with impaired antigen presentation.